Inclusion Criteria:  ≥18 years Males and females Confirmed clinical diagnosis of COVID-19 positive by Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) and/or SARS-CoV-2 Antigen Test performed 120 hours prior to patient inclusion in the study LDH 250-400 U/L Acceptance of informed consent signature IMC: 18.5-30 Patients not participating in other trials No hepatic and renal disorders Possession of mental faculties to participate in the study  Exclusion Criteria:  Patients with rare and specific viral diseases such as HIV Patients undergoing chemotherapy during the last 2 months Any other condition/pathology diagnosed by the medical specialist that prevents them from participating in the trial Intake of vitamin complexes or functional foods